Hypofunction of the N-methyl-D-aspartate receptor (NMDAR) has been implicated as a possible mechanism underlying cognitive deficits and aberrant neuronal dynamics in schizophrenia. To test this hypothesis, we first administered a sub-anaesthetic dose of S-ketamine (0.006 mg/kg/min) or saline in a single-blind crossover design in 14 participants while magnetoencephalographic data were recorded during a visual task. In addition, magnetoencephalographic data were obtained in a sample of unmedicated first-episode psychosis patients (n = 10) and in patients with chronic schizophrenia (n = 16) to allow for comparisons of neuronal dynamics in clinical populations versus NMDAR hypofunctioning. Magnetoencephalographic data were analysed at source-le...
At subanaesthetic doses, ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has demonstra...
International audienceBACKGROUND: Single subanesthetic doses of ketamine, a non-competitive NMDA rec...
Acute treatment with subanesthetic ketamine, a non-competitive N-methyl-D-aspartic acid (NMDA) recep...
Hypofunction of the N-methyl-D-aspartate receptor (NMDAR) has been implicated as a possible mechanis...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Abnormal gamma-band oscillations (GBO) have been frequently associated with the pathophysiology of s...
Acute administration of N-methyl-D-aspartate receptor (NMDAR) antagonists in healthy humans and anim...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
N-methyl-D-aspartate receptor (NMDAR) hypofunction is a leading pathophysiological model of schizoph...
Item does not contain fulltextThe non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) an...
Auditory verbal hallucinations (AVH) are a common positive symptom of schizophrenia. Excitatory-to-i...
ABSTRACT BACKGROUND: Disconnections in cortical-related networks, the neuronal circuits of higher-o...
Background: Working memory (WM) deficits are a core feature of schizophrenia. Electrophysiological s...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
At subanaesthetic doses, ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has demonstra...
International audienceBACKGROUND: Single subanesthetic doses of ketamine, a non-competitive NMDA rec...
Acute treatment with subanesthetic ketamine, a non-competitive N-methyl-D-aspartic acid (NMDA) recep...
Hypofunction of the N-methyl-D-aspartate receptor (NMDAR) has been implicated as a possible mechanis...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Hypofunctioning of the N-methyl-D-aspartate receptor (NMDA-R) has been prominently implicated in the...
Abnormal gamma-band oscillations (GBO) have been frequently associated with the pathophysiology of s...
Acute administration of N-methyl-D-aspartate receptor (NMDAR) antagonists in healthy humans and anim...
International audienceIn prodromal and early schizophrenia, disorders of attention and perception ar...
N-methyl-D-aspartate receptor (NMDAR) hypofunction is a leading pathophysiological model of schizoph...
Item does not contain fulltextThe non-competitive N-methyl d-aspartate glutamate receptor (NMDAR) an...
Auditory verbal hallucinations (AVH) are a common positive symptom of schizophrenia. Excitatory-to-i...
ABSTRACT BACKGROUND: Disconnections in cortical-related networks, the neuronal circuits of higher-o...
Background: Working memory (WM) deficits are a core feature of schizophrenia. Electrophysiological s...
Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of ...
At subanaesthetic doses, ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has demonstra...
International audienceBACKGROUND: Single subanesthetic doses of ketamine, a non-competitive NMDA rec...
Acute treatment with subanesthetic ketamine, a non-competitive N-methyl-D-aspartic acid (NMDA) recep...